Trial Profile
Effects of aggressive lipid-lowering therapy on atherosclerosis and multi-lipoprotein profiling in patients with coronary artery disease.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Oct 2015
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary)
- Indications Angina pectoris; Coronary artery disease; Hypercholesterolaemia; Myocardial infarction; Unstable angina pectoris
- Focus Pharmacodynamics
- Acronyms SAMURAI-Secondary
- 28 Sep 2015 Status changed from active, no longer recruiting to completed, as reported by University Hospital Medical Information Network - Japan.
- 20 Apr 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 22 Dec 2009 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.